Back to Search
Start Over
Denosumab biosimilar (LY06006) in Chinese postmenopausal osteoporotic women: A randomized, double-blind, placebo-controlled, multicenter phase III study
- Source :
- Journal of Orthopaedic Translation; January 2023, Vol. 38 Issue: 1 p117-125, 9p
- Publication Year :
- 2023
-
Abstract
- This study assessed the efficacy, safety, pharmacokinetics (PK), and immunogenicity profiles of a denosumab biosimilar (LY06006) in Chinese postmenopausal osteoporotic women with a high risk of fracture.
Details
- Language :
- English
- ISSN :
- 2214031X
- Volume :
- 38
- Issue :
- 1
- Database :
- Supplemental Index
- Journal :
- Journal of Orthopaedic Translation
- Publication Type :
- Periodical
- Accession number :
- ejs61922350
- Full Text :
- https://doi.org/10.1016/j.jot.2022.06.007